Clinical trial
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
NCT04257045 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 21, 2019
- Completion date
- July 9, 2024
- Enrollment
- 46 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
breast carcinoma, deleterious cdh1 gene mutation, deleterious dicer1 gene mutation, deleterious smarca4 gene mutation, deleterious stk11 gene mutation, endometrial carcinoma, fallopian tube carcinoma, ovarian carcinoma, primary peritoneal carcinoma